Pharmacists’ Group Pushes Fundamental Change In Supplement Regulation
This article was originally published in The Tan Sheet
Executive SummaryConcern about possibly harmful interactions between dietary supplements and drugs has prompted the American Society of Health-System Pharmacists to recommend that Congress fundamentally change the regulation of supplements by requiring pre-market approval of the products
You may also be interested in...
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.
Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.